Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cryoneurolysis to reduce post-stroke spasticity and measure brain changes

Official title: Cryoneurolysis for Spasticity Treatment: Quantifying Long-term Clinical Outcomes and Exploring Mechanisms Within the Central Nervous System

Run by Western University, Canada · NCT06958289 · Data updated 2026-11-12

This will try cryoneurolysis to reduce arm and hand spasticity in people after stroke and track related brain activity with TMS, MRI, and fNIRS for six months.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorWestern University, Canada
Academic / other
Locations1 site (London, Ontario)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedDecember 1, 2027
Study endsMay 1, 2028
Registry record updatedApril 21, 2026
Trial IDNCT06958289 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with focal post-stroke spasticity who improve with a diagnostic nerve block, have at least flicker movement in the affected arm, are 3+ on the Modified Ashworth Scale, and have not received botulinum-A injections within three months are the intended candidates.

Probably not a fit

People with widespread systemic spasticity, recent botulinum toxin use, contraindications to TMS or 3T MRI, severe cognitive impairment, pregnancy, or prior nerve-specific procedures are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Cryoneurolysis delivers a freezing needle alongside a targeted peripheral nerve to produce localized nerve breakdown and reduce focal spasticity. The study enrolls people with post-stroke spasticity who show benefit from a diagnostic nerve block and have at least flicker movement in the affected upper limb. Investigators will record brain and motor system measures using transcranial magnetic stimulation (TMS), structural MRI, and functional near-infrared spectroscopy (fNIRS) before and over six months after treatment. The protocol excludes people with contraindications to TMS or 3T MRI, recent botulinum toxin injections, or inability to consent.

Why it matters

Potential benefit: If successful, cryoneurolysis could offer longer-lasting, targeted reduction of focal post-stroke spasticity and provide insight into brain changes that support durable improvement.

How similar studies have gone: Peripheral denervation approaches like botulinum toxin are established for focal spasticity and early clinical reports of cryoneurolysis are promising, but long-term central nervous system effects from cryoneurolysis remain novel and not yet widely proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* have increased range of motion or reduced spasticity with diagnostic nerve block,
* have no undesired loss of function with a diagnostic nerve block,
* score 2 or higher in the Modified Ashworth scale,
* have at least flickers of movement in the upper extremity,
* have not received botulinum-A neurotoxin within the past 3 months,
* if on anti-spastic medication, maintaining anti-spastic medications on a stable schedule over the course of the follow up period, and
* they can understand and follow instructions in English.

Exclusion Criteria:

* have contraindications to TMS (i.e., history of seizure, pregnancy) or 3T MRI (i.e., certain metallic implants),

  * are unable to provide informed consent (i.e., severe cognitive impairment),
  * receive any toxin injections for spasticity (Botulinum-A Toxin or equivalent) within 3 months of initial baseline assessments or at any time over the course of the follow-up period.
  * Have previously undergone any nerve-specific interventions (phenol neurolysis, radio-frequency ablation, or cryoneurolysis) for spasticity on a nerve that will be targeted for this study.

Where it's running

  • Parkwood Institute
    London, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.